erythrosine has been researched along with dalteparin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dachary-Prigent, J; de Raucourt, E; Fischer, AM; Jozefowicz, M; Mauray, S; Talbot, JC | 1 |
| Handschin, AE; Hoerstrup, SP; Kock, HJ; Trentz, O; Trentz, OA; Wanner, GA | 1 |
2 other study(ies) available for erythrosine and dalteparin
| Article | Year |
|---|---|
Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
Topics: Anticoagulants; Antithrombins; Dalteparin; Enoxaparin; Enzyme Inhibitors; Factor IXa; Fluoresceins; Fluorescence Polarization; Fluorescent Dyes; Heparin; Humans; Kinetics; Nadroparin; Polysaccharides; Protein Binding | 1998 |
Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro.
Topics: Alkaline Phosphatase; Anticoagulants; Cells, Cultured; Dalteparin; Fluoresceins; Fondaparinux; Gene Expression; Humans; Osteoblasts; Osteocalcin; Osteoporosis; Polysaccharides; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Thromboembolism | 2005 |